Blood Transfusion Institute Vojvodina, 21000 Novi Sad, Serbia.
Faculty of Medicine in Novi Sad, University of Novi Sad, 21000 Novi Sad, Serbia.
Int J Environ Res Public Health. 2021 Dec 21;19(1):42. doi: 10.3390/ijerph19010042.
Passive immunotherapy with convalescent COVID-19 plasma (CCP) is used as a therapeutic procedure in many countries, including Serbia. In this study, we analyzed the association between demographic factors, COVID-19 severity and the reactivity of anti-SARS-CoV-2 antibodies (Abs) in Serbian CCP donors. Individuals ( = 468) recovered from confirmed SARS-CoV-2 infection, and who were willing to donate their plasma for passive immunization of COVID-19 patients were enrolled in the study. Plasma samples were tested for the presence of IgG reactive to SARS-CoV-2 spike glycoprotein (S1) and nucleocapsid antigens. Individuals were characterized according to age, gender, comorbidities, COVID-19 severity, ABO blood type and RhD factor. Total of 420 candidates (420/468; 89.74%) reached the levels of anti-SARS-CoV-2 IgG that qualified them for inclusion in CCP donation program. Further statistical analysis showed that male individuals ( = 0.034), older age groups ( < 0.001), existence of hypertension ( = 0.008), and severe COVID-19 ( = 0.000) are linked with higher levels of anti-SARS-CoV-2 Abs. These findings will guide the selection of CCP donors in Serbia. Further studies need to be conducted to assess the neutralization potency and clinical efficiency of CCP collected from Serbian donors with high anti-SARS-CoV-2 IgG reactivity.
恢复期 COVID-19 血浆(CCP)的被动免疫疗法在许多国家(包括塞尔维亚)被用作治疗程序。在这项研究中,我们分析了塞尔维亚 CCP 供体的人口统计学因素、COVID-19 严重程度和抗 SARS-CoV-2 抗体(Abs)反应性之间的关联。从确诊的 SARS-CoV-2 感染中康复并愿意捐献其血浆用于 COVID-19 患者被动免疫的个体被纳入研究。检测血浆样本中是否存在针对 SARS-CoV-2 刺突糖蛋白(S1)和核衣壳抗原的 IgG。根据年龄、性别、合并症、COVID-19 严重程度、ABO 血型和 RhD 因子对个体进行特征描述。共有 420 名候选人(420/468;89.74%)达到了有资格纳入 CCP 捐献计划的抗 SARS-CoV-2 IgG 水平。进一步的统计分析表明,男性个体( = 0.034)、年龄较大的群体(<0.001)、存在高血压( = 0.008)和严重 COVID-19( = 0.000)与更高水平的抗 SARS-CoV-2 Abs 相关。这些发现将指导塞尔维亚 CCP 供体的选择。需要进一步研究评估来自具有高抗 SARS-CoV-2 IgG 反应性的塞尔维亚供体的 CCP 的中和效力和临床疗效。